Leptin Signaling in Lean and Obese Humans

NCT01297426 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-12-24

No results posted yet for this study

Summary

Obesity does not respond to high circulating levels of the hormone leptin. This study is aiming at finding out why this happens and open new avenues for treatment of obesity.

Conditions

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Christos Mantzoros, MD DSc · VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01297426 on ClinicalTrials.gov